Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey
Genetics in MedicinePublished 1 October 2010Open access
Maren T. Scheuner, Timothy S. McNeel, Andrew N. Freedman
Citations78
SJR quartileQ1
SJR score2.68
SNIP2.38
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
We provide population-based prevalence estimates for moderate and strong familial risk for five common cancers and hereditary breast-ovarian cancer and hereditary nonpolyposis colon cancer. Such estimates are helpful in planning and evaluation of genetic services and prevention programs, and assessment of cancer surveillance and prevention strategies.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
JNCI Journal of the National Cancer InstituteRevised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
3,183 Citations2004Asad Umar, C. Richard Boland +21 more
This commentary summarizes the Workshop presentations on HNPCC and MSI testing; presents the issues relating to the performance, specificity, and specificity of the Bethesda Guidelines; outlines the revised Bethesda Guidelines for identifying individuals at risk for H NPCC; and recommend criteria for MSI testing.
GastroenterologyNew clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆
2,511 Citations1999Hans F. A. Vasen, Peter H. Watson +2 more
The establishment of a set of selection criteria for families with hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) to provide a basis for uniformity in collaborative studies and a definition of HNPCC was proposed that was aimed at helping clinicians to identify families.
CA A Cancer Journal for CliniciansAmerican Cancer Society Guidelines for the Early Detection of Cancer
1,598 Citations2002Robert A. Smith, Vilma Cokkinides +7 more
Clinical GerontologistGuide to Clinical Preventive Services
448 Citations1993David Haber
The physician's degree of resourcefulness, i.e., the ability to deal skillfully and promptly with new situations, is important for changing the health behaviors of patients within the constraints of a brief office visit, was in short supply among primary care physicians selected for their interest in preventive medicine.
JAMADoes This Patient Have a Family History of Cancer?
315 Citations2004Harvey J. Murff, David R. Spigel +1 more
Patient-reported family cancer histories for first-degree relatives are accurate and valuable for breast and colon cancer risk assessments, and negative family history reports for ovarian and endometrial cancers are less useful, although the prevalence of these malignancies within families is low.
American Journal of EpidemiologyValidity of self-reported Cancers in a Propsective Cohort Study in Comparison with Data from State Cancer Registries
262 Citations1998Manuela M. Bergmann, Eugenia E. Calle +4 more
The ability of members of this cohort to report a past diagnosis of cancer accurately is quite high, especially for cancers of the breast, prostate, lung, and colon, or for the occurrence of any cancer.
American Journal of Medical GeneticsFamily history: A comprehensive genetic risk assessment method for the chronic conditions of adulthood
252 Citations1997Maren T. Scheuner, Sue-Jane Wang +3 more
Family history reports of common, chronic disease are prevalent among the population at large, and collection and interpretation of comprehensive family history data is a feasible, initial method for risk stratification for many preventable, chronic conditions.
American Journal of Preventive MedicineValidation of family history data in cancer family registries
238 Citations2003Argyrios Ziogas, Hoda Anton‐Culver
High reliability of probands' reporting on most cancer sites when they reported on first-degree relatives and moderate reliability for their reporting on second- and third- Degree relatives is found.
Gynecologic OncologyThe Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal Cancer
234 Citations2001Patrice Watson, Ralf Bützow +7 more
HNPCC patients with ovarian cancer are more likely to have a synchronous endometrial cancer than other ovarian cancer patients and are morelikely to be diagnosed at an early stage, compared with the general population.
Genetics in MedicinePopulation-based study of the prevalence of family history of cancer: Implications for cancer screening and prevention
161 Citations2006Scott D. Ramsey, Paula W. Yoon +2 more
A substantial proportion of persons in the United States report having a close family member with cancer, and thus may be eligible for earlier or more aggressive cancer screening services.
Journal of Medical GeneticsReferral for cancer genetics consultation: a review and compilation of risk assessment criteria
158 Citations2004Heather Hampel, K Sweet +3 more
Based on family history, a set of criteria was developed to identify patients at risk for a hereditary cancer susceptibility syndrome, patients with moderate risk who might benefit from increased cancer surveillance, and patients who are at average risk.
PubMedFamily history: the three-generation pedigree.
94 Citations2005Daniel J Wattendorf, Donald W. Hadley
The collection of a family history ranges from simply asking patients if family members have the same presenting illness to diagramming complex medical and psychosocial relationships as part of aFamily genogram.
PubMedHereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
77 Citations2007Peter A Bonis, Thomas A Trikalinos +5 more
There exists a major gap in the published literature with regard to the accuracy and reliability of specific tests used in the evaluation of HNPCC and limited data suggested that testing probands for MMR mutations was not associated with severe psychological impact following formal counseling.
Journal of Medical GeneticsSurvival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds
74 Citations2009Eli Marie Grindedal, Laura Renkonen‐Sinisalo +15 more
In the series examined, infiltrating ovarian cancer in Lynch syndrome had a better prognosis than infiltrating Ovarian cancer in BRCA1/2 mutation carriers or in the general population.
American Journal of Medical Genetics Part C Seminars in Medical GeneticsContribution of Mendelian disorders to common chronic disease: Opportunities for recognition, intervention, and prevention
56 Citations2004Maren T. Scheuner, Paula W. Yoon +1 more
Genetic testing is available for most Mendelian disorders, which can further clarify the genetic risk, and for some, recommendations for management and prevention are available, however, evidence‐based guidelines are needed.
Journal of Experimental & Clinical Cancer ResearchSurvival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients
42 Citations2008Vittoria Stigliano, D. Assisi +7 more
Overall survival of colorectal cancer in patients with HNPCC is better than sporadic CRC patients, and the different outcome probably relates to the specific tumorigenesis involving DNA mismatch repair dysfunction.
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility
38 Citations2005Heidi D Nelson, Laurie Hoyt Huffman +4 more
Gynecologic OncologyPrognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma
37 Citations2009Joyce F. Liu, Michelle S. Hirsch +2 more
The results suggest that ovarian cancer in younger patients differs biologically from that in older patients, and in the younger patient cohort, there is a trend towards longer overall survival for ER/PR positive tumors.
Cancer Epidemiology Biomarkers & PreventionSurvival After Colorectal Cancer Diagnosis Is Associated with Colorectal Cancer Family History
34 Citations2008Jason A. Zell, Jane Honda +2 more
CRC cases with family history of the disease have improved overall survival compared with sporadic CRC cases, a finding that is independent of other relevant clinical factors.
British Journal of CancerAge of onset in familial breast cancer as background data for medical surveillance
31 Citations2009Andreas Brandt, Justo Lorenzo Bermejo +2 more
Differences in the age of onset of breast cancer and death by breast cancer between women with and without a family history are provided to derive recommendations for the starting age of screening in women with affected family members.
Acta Obstetricia Et Gynecologica ScandinavicaRisk of ovarian cancer in women with first‐degree relatives with cancer
29 Citations2009Marie Soegaard, Kirsten Frederiksen +7 more
Ovarian cancer in a first‐degree relative is a very strong predictor of epithelial ovarian cancer, especially early‐onset ovarian cancer and seems to be positively associated with especially non‐mucinous tumors.
PubMedComparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
20 Citations2009Mahdi Montazer Haghighi, Mohsen Vahedi +4 more
The findings corroborate the results of previous studies which showed overall survival of colorectal cancer in patients with HNPCC is better than with sporadic CRC patients.
Diseases of the Colon & RectumIdentification and Classification of Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Adapting Old Concepts to Recent Advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group
13 Citations2007Maurizio Ponz de Leòn, Lucio Bertario +8 more
The conclusions were similar to the recently proposed “European guidelines for the clinical management of HNPCC,” although the term “clinical hereditary nonpolyposis colorectal cancer” should be reserved for those families that meet the Amsterdam criteria but without evidence of mismatch repair impairment.